Dehydrocorydaline
Dehydrocorydaline Basic information
- Product Name:
- Dehydrocorydaline
- Synonyms:
-
- 13-Methylpalmatine
- dehydeocorydaline
- Dehydrocorydaline
- DEHYDROCORYDALINE98%
- 13-Methyl-2,3,9,10-tetramethoxy-5,6-dihydrodibenzo[a,g]quinolizinium
- 5,6-Dihydro-2,3,9,10-tetramethoxy-13-methyldibenzo[a,g]quinolizinium
- Dibenzo[a,g]quinolizinium,5,6-dihydro-2,3,9,10-tetramethoxy-13-methyl-
- acetate salt of Dehydrocorydaline
- CAS:
- 30045-16-0
- MF:
- C22H24NO4
- MW:
- 0
- Product Categories:
-
- chemical reagent
- pharmaceutical intermediate
- phytochemical
- reference standards from Chinese medicinal herbs (TCM).
- standardized herbal extract
- Mol File:
- 30045-16-0.mol
Dehydrocorydaline Chemical Properties
- Melting point:
- 170-173℃
- storage temp.
- Inert atmosphere,Room Temperature
- solubility
- Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
- form
- Cryst.
- Stability:
- Hygroscopic
Dehydrocorydaline Usage And Synthesis
Chemical Properties
Yellow needle crystal powder, soluble in methanol, ethanol, DMSO and other organic solvents, derived from Corydalis Corydalis, Yuanhu.
Uses
Dehydrocordine has analgesic and sedative effects. It was used for content determination/identification/pharmacological experiments, etc.
Definition
ChEBI: Dehydrocorydaline is an alkaloid.
Biological Activity
Dehydrocorydaline (13-Methylpalmatine) is an alkaloid isolated from the traditional Chinese medicine Corydalis yanhusuo. It can enhance p38 MAPK activation and has anti-inflammatory and anti-cancer effects. Also Dehydrocorydaline has potent antimalarial effects and low cytotoxicity (cell viability > 90%), P. falciparum 3D7 strain (IC50=38 nM).
in vitro
Dehydrocorydaline (0-200 μM) treatment significantly inhibits the growth of MCF-7 cells in a dose-dependent manner. The cell viability is decreased by approximate 40% after 24 h of 200 μM Dehydrocorydaline.
Dehydrocorydaline (0-200 μM) dose-dependently increases Bax protein expression and decreases Bcl-2 protein expression.
Dehydrocorydaline (0-200 μM) induces activation of caspase-7,-8 and the cleavage of PARP without affecting caspase-9.
in vivo
Dehydrocorydaline manifests a low acute toxicity with an LD 50 of about 277.5±19.0 mg/kg body weight in mice following oral administration and 21.1±1.4 mg/kg for intraperitoneal injection. < /p>
target
| Bcl-2 < span> | Bax
| Caspase-7
| Caspase-8
| PARP
|
DehydrocorydalineSupplier
- Tel
- 021-20908456
- sales@BioChemBest.com
- Tel
- 0411-62910999 13889544652
- sales@meilune.com
- Tel
- 0871-65217109 13211707573;
- y.liu@mail.biobiopha.com
- Tel
- 021-61312847 13636370518
- shyysw007@163.com
- Tel
- +86-028-82633397 18982077548
- cwb1@biopurify.cn
Dehydrocorydaline(30045-16-0)Related Product Information
- Protopine
- VERATRIDINE
- Tetrahydropalmatine
- Daurinoline
- corydalmine
- Tetrahydroberberine
- Xanthiside
- 2-[2-(Methylamino)benzoyl]-3,4-dihydro-β-carboline-1(2H)-one
- daurisoline
- menisdaurin
- Dehydrohydrogen fumarate
- 2,9,10-Trimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium-3-ol
- Palmatine
- Dehydrocorydaline nitrate
- Dehydrocorydaline
- columbamine
- 3-PHENYLISOQUINOLINE
- 4-(Isoquinolin-3-yl)phenol